Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evaluating the Antinociceptive Efficacy of Cannabidiol Alone or in Combination with Morphine Using the Formalin Test in Male and Female Mice
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
Cannabis and Cannabinoid Research (2021) Vol. 7, Iss. 5, pp. 648-657
Open Access | Times Cited: 19

Showing 19 citing articles:

Single and Combined Effects of Cannabigerol (CBG) and Cannabidiol (CBD) in Mouse Models of Oxaliplatin-Associated Mechanical Sensitivity, Opioid Antinociception, and Naloxone-Precipitated Opioid Withdrawal
Sean A. Hayduk, Amanda C. Hughes, Rachel L. Winter, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1145-1145
Open Access | Times Cited: 6
The Use of Compounds Derived from Cannabis sativa in the Treatment of Epilepsy, Painful Conditions, and Neuropsychiatric and Neurodegenerative Disorders
Anna Stasiłowicz-Krzemień, Wiktoria Nogalska, Zofia Maszewska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5749-5749
Open Access | Times Cited: 6
Cannabigerol (CBG) attenuates mechanical hypersensitivity elicited by chemotherapy‐induced peripheral neuropathy
Diana E. Sepúlveda, Daniel P. Morris, Wesley M. Raup‐Konsavage, et al.
European Journal of Pain (2022) Vol. 26, Iss. 9, pp. 1950-1966
Closed Access | Times Cited: 25
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
Rosaria Greco, Miriam Francavilla, Chiara Demartini, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 14
Endogenous opiates and behavior: 2022
Richard J. Bodnar
Peptides (2023) Vol. 169, pp. 171095-171095
Closed Access | Times Cited: 13
Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model
Anjalika Eeswara, Amanda Pacheco-Spiewak, Stanislava Jergová, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0282920-e0282920
Open Access | Times Cited: 12
Cannabidiol interactions with oxycodone analgesia in an operant orofacial cutaneous thermal pain assay following oral administration in rats
Ariana C. Brice‐Tutt, Niall Murphy, Barry Setlow, et al.
Pharmacology Biochemistry and Behavior (2025) Vol. 250, pp. 173968-173968
Closed Access
The Pharmacology of Cannabinoids in Chronic Pain
Alonso Cortez-Resendiz, Timothy J Leiter, S. Riela, et al.
Medical Cannabis and Cannabinoids (2025)
Open Access
Cannabidiol modulates chronic neuropathic pain aversion behavior by attenuation of neuroinflammation markers and neuronal activity in the corticolimbic circuit in male Wistar rats
Gleice Kelli Silva-Cardoso, Willian Lazarini-Lopes, Eduardo Octaviano Primini, et al.
Behavioural Brain Research (2023) Vol. 452, pp. 114588-114588
Closed Access | Times Cited: 10
Antinociceptive Effects of Cannabichromene (CBC) in Mice: Insights from von Frey, Tail-Flick, Formalin, and Acetone Tests
Wesley M. Raup‐Konsavage, Diana E. Sepúlveda, Jian Wang, et al.
Biomedicines (2023) Vol. 12, Iss. 1, pp. 83-83
Open Access | Times Cited: 9
Cannabidiol enhances the antinociceptive effects of morphine and attenuates opioid-induced tolerance in the chronic constriction injury model
Carlos Henrique Alves Jesus, Matheus Vinícius Ferreira, Aléxia Thamara Gasparin, et al.
Behavioural Brain Research (2022) Vol. 435, pp. 114076-114076
Closed Access | Times Cited: 16
Considerations for Cannabinoids in Perioperative Care by Anesthesiologists
Krzysztof Laudański, Justin Wain
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 558-558
Open Access | Times Cited: 14
Effects of cannabidiol, with and without ∆9-tetrahydrocannabinol, on anxiety-like behavior following alcohol withdrawal in mice
Mariam Melkumyan, Vibha M. Annaswamy, Alexandra Evans, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 2
Cannabidiol (CBD): A Systematic Review of Clinical and Preclinical Evidence in the Treatment of Pain
Guillermo Cásedas, Martín de Yarza-Sancho, Víctor López
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1438-1438
Open Access | Times Cited: 2
Efficient Synthesis for Altering Side Chain Length on Cannabinoid Molecules and Their Effects in Chemotherapy and Chemotherapeutic Induced Neuropathic Pain
Wesley M. Raup‐Konsavage, Diana E. Sepúlveda, Daniel P. Morris, et al.
Biomolecules (2022) Vol. 12, Iss. 12, pp. 1869-1869
Open Access | Times Cited: 6
Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors
Robert C. Barnes, Satish Banjara, Melissa C. McHann, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 388, Iss. 2, pp. 655-669
Open Access | Times Cited: 3
Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models
Sitthiphon Bunman, Sombat Muengtaweepongsa, Dilok Piyayotai, et al.
Cannabis and Cannabinoid Research (2023) Vol. 9, Iss. 3, pp. 740-750
Closed Access | Times Cited: 2
Study the Effect of Cannabidiol Topical on Antinociceptive and Anti-inflammatory Activities in Animal Model
Sitthiphon Bunman, Sombat Muengtaweepongsa, Dilok Piyayotai, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1
Medical use of cannabidiol and impact on cancer cell viability
Wesley M. Raup‐Konsavage, Kent E. Vrana
Elsevier eBooks (2023), pp. 335-347
Closed Access
Page 1

Scroll to top